Intech Biopharm Corporation (TPEX:6461)
18.35
+0.25 (1.38%)
May 15, 2025, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.50 billion as of May 15, 2025. Its market cap has decreased by -34.76% in one year.
Market Cap
2.50B
Enterprise Value
3.56B
Revenue
32.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.35
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.50B, a decrease of -37.65%. That is a compound annual growth rate of -4.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 166.19B |
Caliway Biopharmaceuticals | 115.80B |
Bora Pharmaceuticals Co., LTD. | 73.49B |
Lotus Pharmaceutical | 60.56B |
Polaris Group | 32.43B |
Oneness Biotech | 29.46B |
Pegavision | 27.14B |
Lumosa Therapeutics | 26.85B |